Oral gabapentin vs placeboChange in quality of life · adults with SMA types II and III1 finding from 1 reviewDrug treatment for spinal muscular atrophy types II and III 2020 · Cochrane Headline outcomes onlyno estimate extracted1 study · 67 participantsLow
Gabapentin vs placeboQoL · People with primary burning mouth syndrome (BMS), that is, oral mucosal pain with no dental or medical cause for such symptomsThe review found no eligible studies for this question.1 finding from 1 reviewInterventions for treating burning mouth syndrome 2016 · Cochrane All outcomesshort-term (up to 3 months)SoF2: No included studies reported change in QoL.0 studiesNo studies found